Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JACK M MANN

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1376542217
CMS profile
334002
Location
BAYSIDE, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$181,045.34

293 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 3 of 6; records 101–150 of 293 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JACK M MANN

NPI 1376542217 · CMS profile ID 334002

Allopathic & Osteopathic Physicians / Internal Medicine / Pulmonary Disease

BAYSIDE, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 6; records 101–150 of 293 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1376542217?year=2019&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JACK M MANN, NPI 1376542217, CMS profile ID 334002. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 6; records 101–150 of 293 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1376542217?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). JACK M MANN, NPI 1376542217, CMS profile ID 334002. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 6; records 101–150 of 293 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1376542217?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
JACK M MANN, NPI 1376542217, CMS profile ID 334002, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 6; records 101–150 of 293 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1376542217?year=2019&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

293 matching records · $181,045.34 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 293 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 293.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Mallinckrodt Enterprises LLC $119.8808/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704772675 CMS
Mallinckrodt Enterprises LLC $654.5008/27/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704772677 CMS
Mylan Specialty L.P. $17.6108/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694794387 CMS
Insmed, Inc. $5.5608/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693335655 CMS
Mallinckrodt Enterprises LLC $28.0108/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704772673 CMS
Actelion Pharmaceuticals US, Inc. $6.6008/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659758885 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $121.9808/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700147509 CMS
GlaxoSmithKline, LLC. $25.0008/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670373831 CMS
GlaxoSmithKline, LLC. $885.8208/14/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670376033 CMS
GlaxoSmithKline, LLC. $112.3908/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670900807 CMS
Insmed, Inc. $3.2708/14/2019 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693336609 CMS
Mallinckrodt Enterprises LLC $4,200.0008/14/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704772671 CMS
Insmed, Inc. $450.0008/13/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693330791 CMS
Mylan Specialty L.P. $112.4008/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694803349 CMS
Sunovion Pharmaceuticals Inc. $22.6808/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688107873 CMS
Insmed, Inc. $21.9308/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693335605 CMS
Mallinckrodt Enterprises LLC $119.7408/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704772667 CMS
Mallinckrodt Enterprises LLC $636.0008/08/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704772669 CMS
Mylan Specialty L.P. $1,732.0008/08/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694762291 CMS
Mylan Specialty L.P. $11.6708/08/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694762293 CMS
Mylan Specialty L.P. $22.6408/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694792287 CMS
Sunovion Pharmaceuticals Inc. $6.3408/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688107871 CMS
Mallinckrodt Enterprises LLC $4,200.0008/05/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704772665 CMS
GlaxoSmithKline, LLC. $600.0007/31/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671515077 CMS
Insmed, Inc. $27.1107/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693325599 CMS
Insmed, Inc. $3.2707/30/2019 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693333731 CMS
Insmed, Inc. $0.9407/30/2019 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693333733 CMS
United Therapeutics Corporation $14.1307/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703102581 CMS
Mallinckrodt Enterprises LLC $135.2207/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704772661 CMS
Mallinckrodt Enterprises LLC $721.0007/25/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704772663 CMS
GlaxoSmithKline, LLC. $33.7107/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670699653 CMS
Mylan Specialty L.P. $102.3107/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694812355 CMS
Sunovion Pharmaceuticals Inc. $4.6907/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688107869 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.5407/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700147407 CMS
Philips Electronics North America Corporation $19.7107/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684063099 CMS
Mallinckrodt Enterprises LLC $28.7707/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704772659 CMS
Insmed, Inc. $9.3507/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693325589 CMS
GlaxoSmithKline, LLC. $3,600.0007/09/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670379325 CMS
Mylan Specialty L.P. $2,598.0007/09/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694766841 CMS
Mylan Specialty L.P. $410.6107/09/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694766843 CMS
Mylan Specialty L.P. $405.6707/09/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694766845 CMS
Mylan Specialty L.P. $34.1007/09/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694766847 CMS
Regeneron Healthcare Solutions, Inc. $18.4707/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673428589 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $2,230.0007/03/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700147421 CMS
GlaxoSmithKline, LLC. $11.3907/03/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671308023 CMS
Mallinckrodt Enterprises LLC $33.9407/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704772657 CMS
Sunovion Pharmaceuticals Inc. $2,100.0006/27/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688107853 CMS
Sunovion Pharmaceuticals Inc. $710.8706/27/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688107855 CMS
Sunovion Pharmaceuticals Inc. $122.2706/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688107857 CMS
GlaxoSmithKline, LLC. $60.8906/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671380339 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $181,045.34 293
PY2020 $151,134.03 175
PY2021 $120,680.19 179
PY2022 $120,643.79 170
PY2023 $44,350.75 116
PY2024 $50,637.67 113
PY2025 $67,535.82 157

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $2,005.10 17
PY2024 Principal investigator $3,164.84 18
PY2023 Principal investigator $2,638.44 3
PY2022 Principal investigator $171,467.24 47
PY2021 Principal investigator $50,663.12 42

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

17 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Insmed, Inc. $149.40 04/28/2025 Non-covered Recipient Entity
Heart and Lung Associates
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact No dispute reported 06/30/2026 1189646966
Principal investigator 1 Insmed, Inc. $122.40 04/28/2025 Non-covered Recipient Entity
Heart and Lung Associates
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact No dispute reported 06/30/2026 1189646968
Principal investigator 1 Insmed, Inc. $21.84 04/28/2025 Non-covered Recipient Entity
Heart and Lung Associates
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact No dispute reported 06/30/2026 1189646970
Principal investigator 1 Insmed, Inc. $21.84 04/28/2025 Non-covered Recipient Entity
Heart and Lung Associates
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact No dispute reported 06/30/2026 1189646972
Principal investigator 1 Insmed, Inc. $136.20 04/28/2025 Non-covered Recipient Entity
Heart and Lung Associates
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact No dispute reported 06/30/2026 1189646974
Principal investigator 1 Insmed, Inc. $132.36 04/28/2025 Non-covered Recipient Entity
Heart and Lung Associates
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact No dispute reported 06/30/2026 1189646976
Principal investigator 1 Insmed, Inc. $122.40 04/28/2025 Non-covered Recipient Entity
Heart and Lung Associates
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact No dispute reported 06/30/2026 1189646978
Principal investigator 1 Insmed, Inc. $21.84 04/28/2025 Non-covered Recipient Entity
Heart and Lung Associates
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact No dispute reported 06/30/2026 1189646980
Principal investigator 1 Insmed, Inc. $120.60 04/28/2025 Non-covered Recipient Entity
Heart and Lung Associates
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact No dispute reported 06/30/2026 1189646982
Principal investigator 1 Insmed, Inc. $120.60 04/28/2025 Non-covered Recipient Entity
Heart and Lung Associates
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact No dispute reported 06/30/2026 1189646984
Principal investigator 1 Insmed, Inc. $142.44 04/28/2025 Non-covered Recipient Entity
Heart and Lung Associates
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact No dispute reported 06/30/2026 1189646986
Principal investigator 1 Insmed, Inc. $118.56 04/28/2025 Non-covered Recipient Entity
Heart and Lung Associates
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact No dispute reported 06/30/2026 1189646988
Principal investigator 1 Insmed, Inc. $136.20 04/28/2025 Non-covered Recipient Entity
Heart and Lung Associates
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact No dispute reported 06/30/2026 1189646990
Principal investigator 1 Insmed, Inc. $153.00 04/28/2025 Non-covered Recipient Entity
Heart and Lung Associates
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact No dispute reported 06/30/2026 1189646992
Principal investigator 1 Insmed, Inc. $50.34 04/28/2025 Non-covered Recipient Entity
Heart and Lung Associates
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact No dispute reported 06/30/2026 1189646994
Principal investigator 1 Insmed, Inc. $151.20 04/28/2025 Non-covered Recipient Entity
Heart and Lung Associates
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact No dispute reported 06/30/2026 1189646996
Principal investigator 1 Insmed, Inc. $283.88 04/28/2025 Non-covered Recipient Entity
Heart and Lung Associates
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact No dispute reported 06/30/2026 1189646998